Éric Van Ganse

5.5k total citations
169 papers, 3.3k citations indexed

About

Éric Van Ganse is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Éric Van Ganse has authored 169 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Physiology, 72 papers in Pulmonary and Respiratory Medicine and 28 papers in Surgery. Recurrent topics in Éric Van Ganse's work include Asthma and respiratory diseases (70 papers), Respiratory and Cough-Related Research (45 papers) and Inhalation and Respiratory Drug Delivery (26 papers). Éric Van Ganse is often cited by papers focused on Asthma and respiratory diseases (70 papers), Respiratory and Cough-Related Research (45 papers) and Inhalation and Respiratory Drug Delivery (26 papers). Éric Van Ganse collaborates with scholars based in France, United Kingdom and United States. Éric Van Ganse's co-authors include Laurent Laforest, Gilles Devouassoux, Manon Belhassen, Pietro Folino-Gallo, Alexandra L. Dima, Marijn de Bruin, Nicholas Moore, H Schneid, P. Stephens and T Walley and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Stroke.

In The Last Decade

Éric Van Ganse

165 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éric Van Ganse France 32 1.4k 1.2k 538 494 438 169 3.3k
Lucie Blais Canada 44 1.8k 1.3× 1.6k 1.3× 1.2k 2.2× 696 1.4× 698 1.6× 196 5.9k
Francesco Lapi Italy 33 556 0.4× 810 0.7× 469 0.9× 273 0.6× 507 1.2× 163 4.2k
Manel Pladevall United States 27 1.1k 0.8× 719 0.6× 250 0.5× 258 0.5× 467 1.1× 57 3.4k
Judith K. Jones United States 28 255 0.2× 677 0.6× 238 0.4× 208 0.4× 545 1.2× 120 3.2k
Kenneth A. Lawson United States 28 600 0.4× 349 0.3× 154 0.3× 288 0.6× 97 0.2× 119 2.9k
Judith P. Kelly United States 33 399 0.3× 554 0.5× 552 1.0× 268 0.5× 494 1.1× 66 5.9k
Rami Ben‐Joseph United States 25 712 0.5× 500 0.4× 207 0.4× 147 0.3× 171 0.4× 71 2.1k
NEIL SKOLNIK United States 20 869 0.6× 669 0.6× 398 0.7× 92 0.2× 194 0.4× 109 3.4k
Anders Sundström Sweden 29 256 0.2× 261 0.2× 597 1.1× 293 0.6× 548 1.3× 70 3.7k
Andrew McIvor Canada 29 1.8k 1.3× 1.9k 1.6× 147 0.3× 65 0.1× 174 0.4× 106 3.0k

Countries citing papers authored by Éric Van Ganse

Since Specialization
Citations

This map shows the geographic impact of Éric Van Ganse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Van Ganse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Van Ganse more than expected).

Fields of papers citing papers by Éric Van Ganse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Van Ganse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Van Ganse. The network helps show where Éric Van Ganse may publish in the future.

Co-authorship network of co-authors of Éric Van Ganse

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Van Ganse. A scholar is included among the top collaborators of Éric Van Ganse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Van Ganse. Éric Van Ganse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bridevaux, Pierre‐Olivier, et al.. (2025). Substantial reduction in oral corticosteroid use after biologics initiation in severe asthma: An analysis based on Swiss pharmacy data. Respiratory Medicine. 248. 108312–108312.
2.
Pétré, Benoît, Bernardo Sousa‐Pinto, Jean Bousquet, et al.. (2024). When patient-reported respiratory symptoms shed light on pathophysiology in adult asthma: a cross-sectional study. Scientific Reports. 14(1). 29997–29997. 2 indexed citations
3.
4.
Dziadzko, Mikhail, et al.. (2024). Health Care Resource Use and Total Mortality After Hospital Admission for Severe COVID-19 Infections During the Initial Pandemic Wave in France: Descriptive Study. JMIR Public Health and Surveillance. 10. e56398–e56398. 1 indexed citations
5.
Cottin, Vincent, et al.. (2022). Healthcare resource use and associated costs in patients receiving pirfenidone or nintedanib for idiopathic pulmonary fibrosis. Respiratory Medicine and Research. 83. 100951–100951. 1 indexed citations
6.
Garín, Olatz, Alexandra L. Dima, Éric Van Ganse, et al.. (2022). The Inhaler Technique Questionnaire (InTeQ): Development and Validation of a Brief Patient-Reported Measure. International Journal of Environmental Research and Public Health. 19(5). 2591–2591. 4 indexed citations
7.
Whittaker, Hannah, Éric Van Ganse, Christophe Pison, et al.. (2022). Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France. BMJ Open Respiratory Research. 9(1). e001150–e001150. 4 indexed citations
8.
Durieu, I., Quitterie Reynaud, Lydie Lemonnier, et al.. (2021). Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis. Journal of Cystic Fibrosis. 21(1). 88–95. 12 indexed citations
9.
Hernández, Gimena, Olatz Garín, Alexandra L. Dima, et al.. (2018). EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study. Journal of Medical Internet Research. 21(1). e10178–e10178. 65 indexed citations
10.
Dima, Alexandra L., et al.. (2017). Asthma exacerbations and socio-economic status in French adults with persistent asthma: A prospective cohort study. Journal of Asthma. 55(10). 1043–1051. 7 indexed citations
11.
Belhassen, Manon, et al.. (2016). Anti-osteoporotic treatments in France: initiation, persistence and switches over 6 years of follow-up. Osteoporosis International. 28(3). 853–862. 13 indexed citations
12.
Rouillon, F., et al.. (2015). Niveau de vigilance des psychiatres pour les facteurs de risque cardiovasculaire chez les patients schizophrènes. L Encéphale. 41(1). 70–77. 3 indexed citations
13.
Ganse, Éric Van, Nathalie Texier, Alexandra L. Dima, et al.. (2015). Assessment of the safety of long-acting β2-agonists in routine asthma care: the ASTRO-LAB protocol. npj Primary Care Respiratory Medicine. 25(1). 15040–15040. 14 indexed citations
14.
Darmon, David, Laurent Laforest, Éric Van Ganse, et al.. (2015). Prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients in general practice: a cross-sectional study based on French and Italian prescribing data. BMC Family Practice. 16(1). 14–14. 7 indexed citations
15.
Caillet, Pascal, J.C. Souberbielle, Susan Jaglal, et al.. (2013). Vitamin D supplementation in a healthy, middle-aged population: actual practices based on data from a French comprehensive regional health-care database. European Journal of Clinical Nutrition. 67(11). 1133–1137. 7 indexed citations
16.
Laforest, Laurent, Abdelkader El Hasnaoui, C. Pribil, et al.. (2009). Asthma patients' self-reported behaviours toward inhaled corticosteroids. Respiratory Medicine. 103(9). 1366–1375. 40 indexed citations
17.
Laforest, Laurent, Laure Com-Ruelle, Gilles Devouassoux, Christophe Pison, & Éric Van Ganse. (2008). Enjeux économiques de l’asthme sévère. La Presse Médicale. 37(1). 117–128. 3 indexed citations
18.
Laforest, Laurent, Pierre Ernst, G. Pietri, et al.. (2005). Asthma-Related Costs Relative to Severity and Control in General Practice. Pediatric Asthma Allergy & Immunology. 18(1). 36–45. 5 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucie Blais Breakdown of academic impact, for papers by Francesco Lapi Breakdown of academic impact, for papers by Manel Pladevall Breakdown of academic impact, for papers by Judith K. Jones Breakdown of academic impact, for papers by Kenneth A. Lawson Breakdown of academic impact, for papers by Judith P. Kelly Breakdown of academic impact, for papers by Rami Ben‐Joseph Breakdown of academic impact, for papers by NEIL SKOLNIK Breakdown of academic impact, for papers by Anders Sundström Breakdown of academic impact, for papers by Andrew McIvor
Rankless by CCL
2026